カテゴリー： Market Monitor Global, 世界, 医療/バイオ

非ステロイド性抗炎症薬（NSAID）の世界市場見通し2023年-2029年

◆英語タイトル：Non-steroidal Anti-inflammatory Drugs (NSAID) Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5813）

◆商品コード：MMG23JU5813
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 調査レポートは次の情報を含め、グローバルにおけるの非ステロイド性抗炎症薬（NSAID）市場規模と予測を収録しています。・世界の非ステロイド性抗炎症薬（NSAID）市場：売上、2018年-2023年、2024年-2029年
・世界の非ステロイド性抗炎症薬（NSAID）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非ステロイド性抗炎症薬（NSAID）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「サリチル酸塩」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

非ステロイド性抗炎症薬（NSAID）のグローバル主要企業は、Bayer、 Ecotrin、 Generic、 St. Joseph、 Elanco、 Zoetis、 Boehringer Ingelheim、 Merial、 Merck Animal Healthなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、非ステロイド性抗炎症薬（NSAID）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の非ステロイド性抗炎症薬（NSAID）市場：タイプ別、2018年-2023年、2024年-2029年
世界の非ステロイド性抗炎症薬（NSAID）市場：タイプ別市場シェア、2022年
・サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬

世界の非ステロイド性抗炎症薬（NSAID）市場：用途別、2018年-2023年、2024年-2029年
世界の非ステロイド性抗炎症薬（NSAID）市場：用途別市場シェア、2022年
・人間、動物、その他

世界の非ステロイド性抗炎症薬（NSAID）市場：地域・国別、2018年-2023年、2024年-2029年
世界の非ステロイド性抗炎症薬（NSAID）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル売上、2018年-2023年
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル売上シェア、2022年
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル販売量、2018年-2023年
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer、 Ecotrin、 Generic、 St. Joseph、 Elanco、 Zoetis、 Boehringer Ingelheim、 Merial、 Merck Animal Health

*************************************************************

・調査・分析レポートの概要
非ステロイド性抗炎症薬（NSAID）市場の定義
市場セグメント
世界の非ステロイド性抗炎症薬（NSAID）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非ステロイド性抗炎症薬（NSAID）市場規模
世界の非ステロイド性抗炎症薬（NSAID）市場規模：2022年 VS 2029年
世界の非ステロイド性抗炎症薬（NSAID）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非ステロイド性抗炎症薬（NSAID）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非ステロイド性抗炎症薬（NSAID）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬
非ステロイド性抗炎症薬（NSAID）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：人間、動物、その他
非ステロイド性抗炎症薬（NSAID）の用途別グローバル売上・予測

・地域別市場分析
地域別非ステロイド性抗炎症薬（NSAID）市場規模 2022年と2029年
地域別非ステロイド性抗炎症薬（NSAID）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Ecotrin、 Generic、 St. Joseph、 Elanco、 Zoetis、 Boehringer Ingelheim、 Merial、 Merck Animal Health
...

This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID). This report contains market size and forecasts of Non-steroidal Anti-inflammatory Drugs (NSAID) in global, including the following market information:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Non-steroidal Anti-inflammatory Drugs (NSAID) companies in 2022 (%)
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Salicylates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Type, 2022 (%)
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Application, 2022 (%)
Human
Animals
Others
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues share in global market, 2022 (%)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-steroidal Anti-inflammatory Drugs (NSAID), market overview.
Chapter 2: Global Non-steroidal Anti-inflammatory Drugs (NSAID) market size in revenue and volume.
Chapter 3: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-steroidal Anti-inflammatory Drugs (NSAID) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Overall Market Size
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2022 VS 2029
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales: 2018-2029
3 Company Landscape
3.1 Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.2 Top Global Non-steroidal Anti-inflammatory Drugs (NSAID) Companies Ranked by Revenue
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.8.1 List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Markets, 2022 & 2029
4.1.2 Salicylates
4.1.3 Propionic acid derivatives
4.1.4 Acetic acid derivatives
4.1.5 Enolic acid (Oxicam) derivatives
4.1.6 Anthranilic acid derivatives (Fenamates)
4.1.7 Selective COX-2 inhibitors (Coxibs)
4.1.8 Sulfonanilides
4.2 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
4.2.1 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
4.2.2 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2029
4.2.3 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
4.3 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
4.3.1 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
4.3.2 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2029
4.3.3 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
4.4 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2022 & 2029
5.1.2 Human
5.1.3 Animals
5.1.4 Others
5.2 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
5.2.1 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
5.2.2 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2029
5.2.3 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
5.3 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
5.3.1 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
5.3.2 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2029
5.3.3 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
5.4 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2022 & 2029
6.2 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
6.2.1 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
6.2.2 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2029
6.2.3 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
6.3 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
6.3.1 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
6.3.2 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2029
6.3.3 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.4.2 By Country – North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.4.3 US Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.4.4 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.4.5 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.5.2 By Country – Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.5.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.4 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.5 U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.6 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.7 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.8 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.9 Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.6.2 By Region – Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.6.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.7 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.7.2 By Country – South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.7.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.7.4 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.8.3 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8.4 Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8.5 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8.6 UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Ecotrin
7.2.1 Ecotrin Company Summary
7.2.2 Ecotrin Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.2.5 Ecotrin Key News & Latest Developments
7.3 Generic
7.3.1 Generic Company Summary
7.3.2 Generic Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.3.5 Generic Key News & Latest Developments
7.4 St. Joseph
7.4.1 St. Joseph Company Summary
7.4.2 St. Joseph Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.4.5 St. Joseph Key News & Latest Developments
7.5 Elanco
7.5.1 Elanco Company Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.5.5 Elanco Key News & Latest Developments
7.6 Zoetis
7.6.1 Zoetis Company Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.6.5 Zoetis Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Merial
7.8.1 Merial Company Summary
7.8.2 Merial Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.8.5 Merial Key News & Latest Developments
7.9 Merck Animal Health
7.9.1 Merck Animal Health Company Summary
7.9.2 Merck Animal Health Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.9.5 Merck Animal Health Key News & Latest Developments
8 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, Analysis
8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, 2018-2029
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-steroidal Anti-inflammatory Drugs (NSAID) Supply Chain Analysis
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Market
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID) in Global Market
Table 2. Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Companies, 2018-2023
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies, (K Units), 2018-2023
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 9. List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2018-2023
Table 15. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2024-2029
Table 16. By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2018-2023
Table 20. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2024-2029
Table 21. By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2018-2023
Table 25. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2024-2029
Table 26. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 29. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2029
Table 30. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2029
Table 34. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2029
Table 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 41. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2029
Table 46. Bayer Company Summary
Table 47. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 48. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Ecotrin Company Summary
Table 51. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 52. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Ecotrin Key News & Latest Developments
Table 54. Generic Company Summary
Table 55. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 56. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Generic Key News & Latest Developments
Table 58. St. Joseph Company Summary
Table 59. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 60. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. St. Joseph Key News & Latest Developments
Table 62. Elanco Company Summary
Table 63. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 64. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Elanco Key News & Latest Developments
Table 66. Zoetis Company Summary
Table 67. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 68. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Zoetis Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 72. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Boehringer Ingelheim Key News & Latest Developments
Table 74. Merial Company Summary
Table 75. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 76. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merial Key News & Latest Developments
Table 78. Merck Animal Health Company Summary
Table 79. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 80. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Merck Animal Health Key News & Latest Developments
Table 82. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2018-2023 (K Units)
Table 85. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2024-2029 (K Units)
Table 86. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Opportunities & Trends in Global Market
Table 87. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers in Global Market
Table 88. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints in Global Market
Table 89. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials
Table 90. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials Suppliers in Global Market
Table 91. Typical Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream
Table 92. Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Clients in Global Market
Table 93. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type in 2022
Figure 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application in 2022
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029 (US$, Mn)
Figure 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2022
Figure 9. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 12. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 16. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 21. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 23. US Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 28. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 29. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 37. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 41. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 44. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
Figure 48. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Non-steroidal Anti-inflammatory Drugs (NSAID) by Region, 2022 VS 2029
Figure 54. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 非ステロイド性抗炎症薬（NSAID）の世界市場見通し2023年-2029年(Non-steroidal Anti-inflammatory Drugs (NSAID) Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

非ステロイド性抗炎症薬（NSAID）の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp